“…The analysis of diversified biomarkers with high sensitivity and in a point-of-care (POC) manner is significant for early cancer diagnosis. As a typical POC format, lateral flow immunoassay (LFIA) has been widely used in clinical diagnostics, food safety, and drug testing fields over recent decades. − However, the lack of test result precision and poor quantification confine its development in trace detection. Magnetic nanoparticles (MNPs), which exhibit excellent biocompatibility and stability, have served as LFIA labels for the biological detection of various substances and provide higher detection sensitivity. , Compared with the optical detection methods, magnetic LFIAs deliver quantitative measurement results by reading the magnetic signals of MNPs.…”